United Therapeutics Corporation (NasdaqGS:UTHR) is looking for potential acquisitions. James Edgemond, Chief Financial Officer and Treasurer said "Now with respect to business and corporate development, we are constantly looking for potential acquisitions and also in-license opportunities. We tend to be most interested in complementary products and platforms that focus on rare lung and other cardiovascular diseases.

But as you've also seen recently that we disclosed in the 10-K, we did a couple of acquisitions, being IVIVA and Miromatrix. They were focused on organ manufacturing. So we're looking across the board and things that really complement the strengths of Unitherians internally and add to the research and development we're doing".